The Beauty Health Company (NASDAQ:SKIN) Receives Average Recommendation of "Hold" from Brokerages

Key Points

• The Beauty Health Company (NASDAQ:SKIN) received an average rating of "Hold" from analysts, with four hold recommendations and one buy recommendation, and a one-year price target of $2.8125.
• Recent earnings data revealed that Beauty Health reported $0.03 earnings per share, surpassing expectations, with quarterly revenue of $78.2 million, compared to anticipated revenue of $74.67 million.
• Institutional investors hold a significant majority of the company's stock, with hedge funds owning approximately 93.26% of Beauty Health shares.

Shares of The Beauty Health Company (NASDAQ:SKIN - Get Free Report) have received an average rating of "Hold" from the five analysts that are covering the firm, Marketbeat reports. Four investment analysts have rated the stock with a hold recommendation and one has issued a buy recommendation on the company. The average 1 year price target among analysts that have issued ratings on the stock in the last year is $2.8125.

SKIN has been the topic of a number of recent analyst reports. Stifel Nicolaus lifted their price target on Beauty Health from $3.00 to $4.00 and gave the company a "hold" rating in a report on Friday, August 1st. Roth Capital began coverage on Beauty Health in a report on Friday. They set a "buy" rating and a $3.50 price target on the stock. TD Cowen lifted their price objective on shares of Beauty Health from $2.00 to $2.50 and gave the company a "hold" rating in a research note on Monday. Cowen reiterated a "hold" rating on shares of Beauty Health in a research report on Monday. Finally, Wall Street Zen upgraded Beauty Health from a "hold" rating to a "buy" rating in a research report on Saturday, August 9th.

Hedge Funds Weigh In On Beauty Health

A number of institutional investors have recently bought and sold shares of SKIN. ProShare Advisors LLC lifted its stake in Beauty Health by 49.0% during the fourth quarter. ProShare Advisors LLC now owns 20,959 shares of the company's stock valued at $33,000 after buying an additional 6,896 shares in the last quarter. AQR Capital Management LLC acquired a new stake in shares of Beauty Health during the first quarter valued at approximately $40,000. Simplicity Wealth LLC purchased a new stake in shares of Beauty Health in the 2nd quarter valued at approximately $49,000. Nuveen LLC acquired a new position in Beauty Health in the 1st quarter worth approximately $59,000. Finally, Kapitalo Investimentos Ltda purchased a new position in Beauty Health during the 2nd quarter worth approximately $60,000. Hedge funds and other institutional investors own 93.26% of the company's stock.

Beauty Health Stock Performance

Shares of NASDAQ SKIN opened at $2.28 on Tuesday. Beauty Health has a 12-month low of $0.78 and a 12-month high of $2.69. The company has a market cap of $289.15 million, a price-to-earnings ratio of -8.14 and a beta of 1.22. The company has a current ratio of 5.15, a quick ratio of 4.15 and a debt-to-equity ratio of 4.91. The stock's 50 day simple moving average is $2.02 and its 200 day simple moving average is $1.66.

Beauty Health (NASDAQ:SKIN - Get Free Report) last released its quarterly earnings data on Thursday, August 7th. The company reported $0.03 earnings per share for the quarter, topping analysts' consensus estimates of ($0.06) by $0.09. The business had revenue of $78.20 million for the quarter, compared to analysts' expectations of $74.67 million. Beauty Health had a negative net margin of 6.13% and a negative return on equity of 32.82%. Beauty Health has set its FY 2025 guidance at EPS. Q3 2025 guidance at EPS. Equities research analysts expect that Beauty Health will post -0.25 EPS for the current year.

Beauty Health Company Profile

The Beauty Health Company designs, develops, manufactures, markets, and sells aesthetic technologies and products worldwide. The company's flagship product includes HydraFacial that enhance the skin to cleanse, extract, and hydrate the skin with proprietary solutions and serums. Its products also comprise Syndeo, a Delivery System designs to connects providers to the consumer's preferences to create a more personalized experience; consumables, such as single-use tips, solutions, and serums used to provide a hydrafacial treatment; SkinStylus SteriLock Microsystem, a microneedling device used for the treatment of enhancing appearance of surgical or traumatic hypertrophic scars on the abdomen and facial acne scarring in Fitzpatrick skin types I, II, and III; and Keravive, a treatment for scalp health.

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest and most accurate reporting. This story was reviewed by MarketBeat's editorial team prior to publication. Please send any questions or comments about this story to contact@marketbeat.com.